Immunogenicity of a mucosal vaccine against SARS-CoV2 responsible for covid-19
- Funded by Natural Sciences and Engineering Research Council of Canada (NSERC)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$57,000Funder
Natural Sciences and Engineering Research Council of Canada (NSERC)Principal Investigator
Isabelle FortierResearch Location
CanadaLead Research Institution
Cégep de Lévis-LauzonResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Life sciences (including biotechnology); Human pharmaceuticals